TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC
Condition: Advanced Hepatocellular Carcinoma Interventions: Procedure: TACE; Drug: Lenvatinib Sponsor: Sun Yat-sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials